IDHC logo
IDHC
Integrated Diagnostics Holdings

Acquisition And Branch Expansion Will Unlock Middle East Opportunities

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
06 Apr 25
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$0.68
44.5% undervalued intrinsic discount
31 Jul
US$0.38
Loading
1Y
16.3%
7D
6.8%

Author's Valuation

US$0.7

44.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates4

Shared on01 May 25
Fair value Increased 20%

Read more

Shared on23 Apr 25
Fair value Decreased 25%

AnalystConsensusTarget has decreased revenue growth from 19.7% to 13.0% and decreased future PE multiple from 13.6x to 11.8x.

Read more

Shared on17 Apr 25
Fair value Increased 9.68%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25

Read more